Published in BMJ on January 25, 2003
The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry (2005) 2.37
Frequency of consultations and general practitioner recognition of psychological symptoms. Br J Gen Pract (2004) 1.50
The factor structure of the twelve item General Health Questionnaire (GHQ-12): the result of negative phrasing? Clin Pract Epidemiol Ment Health (2008) 1.29
The effectiveness of case-finding for mental health problems in primary care. Br J Gen Pract (2005) 1.24
Physician attitude toward depression care interventions: implications for implementation of quality improvement initiatives. Implement Sci (2008) 1.21
Screening for depression in primary care: will one or two items suffice? Eur Arch Psychiatry Clin Neurosci (2004) 1.10
Depression and low bone mineral density: a meta-analysis of epidemiologic studies. Osteoporos Int (2009) 1.08
Depression, fracture risk, and bone loss: a meta-analysis of cohort studies. Osteoporos Int (2010) 1.08
The WHO-5 Wellbeing Index performed the best in screening for depression in primary care. ACP J Club (2003) 1.03
Controlled prospective evaluation of the diagnostic yield of a laryngopharyngeal screening examination during upper gastrointestinal endoscopy. Gut (2004) 1.00
An Internet-based intervention to promote mental fitness for mildly depressed adults: randomized controlled trial. J Med Internet Res (2013) 0.98
The prevalence of depression in white-European and South-Asian people with impaired glucose regulation and screen-detected type 2 diabetes mellitus. PLoS One (2009) 0.95
A spatial epidemiological analysis of self-rated mental health in the slums of Dhaka. Int J Health Geogr (2011) 0.95
Investigating efficacy of two brief mind-body intervention programs for managing sleep disturbance in cancer survivors: a pilot randomized controlled trial. J Cancer Surviv (2013) 0.92
Mental health in the slums of Dhaka - a geoepidemiological study. BMC Public Health (2012) 0.92
Predictors of Well-Being in Resident Physicians: A Descriptive and Psychometric Study. J Grad Med Educ (2015) 0.89
Workplace social capital and mental health among Chinese employees: a multi-level, cross-sectional study. PLoS One (2014) 0.89
Yield of practice-based depression screening in VA primary care settings. J Gen Intern Med (2012) 0.87
Hope modified the association between distress and incidence of self-perceived medical errors among practicing physicians: prospective cohort study. PLoS One (2012) 0.83
Screening for depression and high utilization of health care resources among patients in primary care. Community Ment Health J (2014) 0.83
Efficacy of a systematic depression management program in high utilizers of primary care: a randomized trial. BMC Health Serv Res (2012) 0.82
Internet-based intervention to promote mental fitness in mildly depressed adults: design of a randomized controlled trial. JMIR Res Protoc (2012) 0.82
Learning by doing: a novel approach to improving general practitioners' diagnostic skills for common mental disorders. Wien Klin Wochenschr (2007) 0.81
Psychosocial stressors and depression at a Swedish primary health care centre. A gender perspective study. BMC Fam Pract (2011) 0.81
Validation of the Chinese SAD PERSONS Scale to predict repeated self-harm in emergency attendees in Taiwan. BMC Psychiatry (2014) 0.80
Evidence for beneficial effects of antidepressants on suicidality in depressive patients: a systematic review. Eur Arch Psychiatry Clin Neurosci (2006) 0.79
COOP/WONCA charts as a screen for mental disorders in primary care. Ann Fam Med (2011) 0.79
Diagnosis of depression among adolescents--a clinical validation study of key questions and questionnaire. BMC Fam Pract (2007) 0.78
Social inequalities in psychological well-being: a European comparison. Community Ment Health J (2014) 0.76
Screening for depression in primary care. Scientific and statistical errors should have been picked up in peer review. BMJ (2003) 0.75
Screening for depression in primary care. Chosen tool makes little sense. BMJ (2003) 0.75
Bioethical and Other Philosophical Considerations in Positive Psychiatry. Mens Sana Monogr (2016) 0.75
Screening for depression in primary care. Study analysis and conclusions are flawed. BMJ (2003) 0.75
Subjective positive well-being. World Psychiatry (2012) 0.75
Association between mental well-being, depression, and periodontal attachment level among young adults of the postwar Sebha city, Libya: A pilot study. J Nat Sci Biol Med (2014) 0.75
Associations between health culture, health behaviors, and health-related outcomes: A cross-sectional study. PLoS One (2017) 0.75
The psychometric properties of the Composite International Diagnostic Interview. Soc Psychiatry Psychiatr Epidemiol (1998) 5.55
The Defeat Depression Campaign: psychiatry in the public arena. Am J Psychiatry (1997) 3.00
Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Suicide prevention strategies: a systematic review. JAMA (2005) 14.79
Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet (2008) 10.52
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet (2003) 6.63
A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34
A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet (2009) 5.01
Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet (2008) 4.78
Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet (2005) 3.24
Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans. J Neurosci (2010) 3.12
Genome-wide association study of alcohol dependence. Arch Gen Psychiatry (2009) 3.08
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet (2003) 3.02
Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression. Br J Psychiatry (2005) 2.84
Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data. Int J Neuropsychopharmacol (2010) 2.74
The diagnosis and treatment of generalized anxiety disorder. Dtsch Arztebl Int (2013) 2.73
Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet (2011) 2.71
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry (2008) 2.64
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One (2010) 2.57
Descending necrotizing mediastinitis: contemporary trends in etiology, diagnosis, management, and outcome. Ann Surg (2010) 2.57
A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest Endosc (2003) 2.47
Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. Nat Genet (2010) 2.46
An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. Am J Psychiatry (2014) 2.43
Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry (2010) 2.41
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care. World J Biol Psychiatry (2007) 2.40
Current state and perspectives of fungal DNA barcoding and rapid identification procedures. Appl Microbiol Biotechnol (2010) 2.24
Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry (2009) 2.17
Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry (2002) 2.15
Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch Gen Psychiatry (2004) 2.12
Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. J Clin Psychiatry (2009) 2.09
Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry (2007) 2.05
Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry (2010) 2.04
Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment. Neuroimage (2007) 2.03
Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. Brain (2005) 2.03
The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron (2011) 2.02
Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet (2002) 1.99
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia. World J Biol Psychiatry (2005) 1.98
Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment. Neurology (2012) 1.94
Maternally derived microduplications at 15q11-q13: implication of imprinted genes in psychotic illness. Am J Psychiatry (2011) 1.94
Dopamine agonists for restless legs syndrome. Cochrane Database Syst Rev (2011) 1.88
Integration of fMRI and simultaneous EEG: towards a comprehensive understanding of localization and time-course of brain activity in target detection. Neuroimage (2004) 1.84
Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol (2008) 1.83
Prefrontal transcranial direct current stimulation changes connectivity of resting-state networks during fMRI. J Neurosci (2011) 1.81
Do schizoaffective disorders exist at all? Acta Psychiatr Scand (2006) 1.79
Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease. Arch Neurol (2005) 1.75
Genomewide association analysis followed by a replication study implicates a novel candidate gene for neuroticism. Arch Gen Psychiatry (2008) 1.75
Factor structure and external validity of the PANSS revisited. Schizophr Res (2005) 1.74
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World J Biol Psychiatry (2012) 1.69
Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Sci Rep (2013) 1.67
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania. World J Biol Psychiatry (2003) 1.66
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry (2002) 1.63
Depression-related variation in brain morphology over 3 years: effects of stress? Arch Gen Psychiatry (2008) 1.61
Rhino-orbital-cerebral mucormycosis and aspergillosis: differential diagnosis and treatment. Eur Arch Otorhinolaryngol (2008) 1.61
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry (2010) 1.61
Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe). Dement Geriatr Cogn Disord (2007) 1.59
Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Arch Neurol (2011) 1.59
A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry (2006) 1.57
No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science (2002) 1.57
Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects. Biol Psychiatry (2003) 1.55
Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas. Eur Arch Psychiatry Clin Neurosci (2008) 1.55
Best practice elements of multilevel suicide prevention strategies: a review of systematic reviews. Crisis (2011) 1.55
Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol (2013) 1.55
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry (2012) 1.55
Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J Psychiatry Neurosci (2008) 1.53
Multivariate network analysis of fiber tract integrity in Alzheimer's disease. Neuroimage (2006) 1.52
Response and remission criteria in major depression--a validation of current practice. J Psychiatr Res (2010) 1.52
Syndromes and phenomenological subtypes underlying acute mania: a factor analytic study of 576 manic patients. Am J Psychiatry (2002) 1.51
Volume reduction of the entorhinal cortex in subjective memory impairment. Neurobiol Aging (2005) 1.51
Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease. J Alzheimers Dis (2009) 1.49
Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract (2012) 1.49
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry (2013) 1.48
Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J Clin Psychiatry (2004) 1.48
The His452Tyr variant of the gene encoding the 5-HT2A receptor is specifically associated with consolidation of episodic memory in humans. Int J Neuropsychopharmacol (2008) 1.48
Prosocial effects of oxytocin and clinical evidence for its therapeutic potential. Front Neuroendocrinol (2011) 1.47
Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch Gen Psychiatry (2010) 1.46
Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry. Brain (2004) 1.45
Antiplatelet effects of antidepressant treatment: a randomized comparison between escitalopram and nortriptyline. Thromb Res (2010) 1.44
A genomewide linkage study on suicidality in major depressive disorder confirms evidence for linkage to 2p12. Am J Med Genet B Neuropsychiatr Genet (2010) 1.44
Progression of corpus callosum atrophy in Alzheimer disease. Arch Neurol (2002) 1.44
Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr Bull (2008) 1.44
Kinematic analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer dementia. J Clin Psychopharmacol (2003) 1.43
The German MultiCare-study: Patterns of multimorbidity in primary health care - protocol of a prospective cohort study. BMC Health Serv Res (2009) 1.43
Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. J Clin Psychiatry (2003) 1.41
Suicidality as rare adverse event of antidepressant medication: report from the AMSP multicenter drug safety surveillance project. J Clin Psychiatry (2010) 1.41
A genome-wide significant linkage for severe depression on chromosome 3: the depression network study. Am J Psychiatry (2011) 1.41
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Arch Neurol (2002) 1.41
Parkinson's disease sleep scale--validation of the revised version PDSS-2. Mov Disord (2011) 1.41
Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression. Biol Psychiatry (2010) 1.39
Altered EEG lagged coherence during rest in obsessive-compulsive disorder. Clin Neurophysiol (2013) 1.39
Acupuncture and moxibustion in the treatment of ulcerative colitis: a randomized controlled study. Scand J Gastroenterol (2006) 1.38
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry (2002) 1.38